#bloodcancers
LightNews LightNews
mskdeptofmed.bsky.social
Research co-led by MSK scientists found a gene variant that may reduce the risk of developing certain #bloodcancers associated with #clonalhematopoiesis. Learn more about how @mskcancercenter.bsky.social is leading the way in CH research and treatment.

Also check out our CH clinic: bit.ly/49szicf
mskcancercenter.bsky.social Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 14d
Scientists have known for decades that there are gene mutations that increase your risk of developing cancer. But there is also a genetic variant that could reduce the risk of developing certain #bloodcancers, according to new research co-led by scientists from MSK.

Learn more: bit.ly/4sIJ5DQ
January 7, 2026 at 7:33 PM
mskcancercenter.bsky.social
Scientists have known for decades that there are gene mutations that increase your risk of developing cancer. But there is also a genetic variant that could reduce the risk of developing certain #bloodcancers, according to new research co-led by scientists from MSK.

Learn more: bit.ly/4sIJ5DQ
January 6, 2026 at 8:02 PM
mullallylab.bsky.social
Excited to kick off 2026 with a #Hematology seminar from Arun Wiita, MD, PhD on Jan 8th! Arun has pioneered proteomics to characterize aberrantly expressed cell surface proteins in #bloodcancers, to identify novel targets for #immunotherapy, looking forward to this! @stanforddeptmed.bsky.social
January 5, 2026 at 7:34 PM
capathfinders.bsky.social
📢Meet our Fellows

Nadya Christina joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Marcus Buschbeck at
@carrerasijc.bsky.social.

👩‍🔬Learn about Nadya carreraspathfinders.eu/doctoral-can...
🔬her project carreraspathfinders.eu/projects/dc14/

#MSCActions #bloodcancers #phd
December 23, 2025 at 11:34 AM
capathfinders.bsky.social
📢Meet our Fellows

Hollie Bunce joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Vincenzo Calvanese at
@carrerasijc.bsky.social.
👩‍🔬Learn about Hollie carreraspathfinders.eu/doctoral-can...
🔬her project carreraspathfinders.eu/projects/dc13/

#MSCActions #bloodcancers #phd
December 23, 2025 at 11:32 AM
capathfinders.bsky.social
📢Meet our Fellows

Galina Medvedeva joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Biola Javierre at @carrerasijc.bsky.social

👩‍🔬Learn about Galina carreraspathfinders.eu/doctoral-can...
🔬her project carreraspathfinders.eu/projects/dc12/

#MSCActions #bloodcancers #phd
December 23, 2025 at 11:28 AM
capathfinders.bsky.social
📢Meet our Fellows

Niladri Koner joined #CarrerasPathfinders to pursue his PhD under the supervision of Dr Sergi Cuartero at @carrerasijc.bsky.social

👨‍🔬Learn about Niladri carreraspathfinders.eu/doctoral-can...
🔬his project carreraspathfinders.eu/projects/dc11/

#MSCActions #bloodcancers #phd
December 23, 2025 at 11:25 AM
ashclinicalnews.bsky.social
Imaging's Hidden Cost: There may be a link between #medical #imaging and childhood #BloodCancers. A retrospective cohort study found that 10.1% of #hematologic cancers in children may be caused by #radiation exposure from medical imaging.
#HemeSky #OncSky
December 5, 2025 at 3:01 PM
pharmaphorum.bsky.social
#BristolMyersSquibb has taken #CARTtherapy of #bloodcancers into new territory, after getting #FDAapproval for Breyanzi as a treatment for relapsed or refractory #marginalzonelymphoma (MZL).

pharmaphorum.com/news/bmss-br...
BMS's Breyanzi is first CAR-T for marginal zone lymphoma
Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanzi in marginal zone lymphoma.
pharmaphorum.com
December 5, 2025 at 11:53 AM
mullallylab.bsky.social
Delighted to welcome Dr. Fred Appelbaum from #FHCRC to Stanford #Hematology today! A giant in #bloodcancers, a superb #physicianscientist &
recently an author of the fab book #LivingMedicine, a history of Dr. Don Thomas, marrow transplant & #celltherapy, a great read!
@stanforddeptmed.bsky.social
November 13, 2025 at 4:32 PM
cancergrace.bsky.social
Missed our #BloodCancers #OncTalk2025 event? 🎥
The full recording is now available on YouTube!
Watch here ⬇️
www.youtube.com/watch?v=6Anm...

#CancerGRACE #CancerEducation #OnDemand
October 30, 2025 at 12:03 AM
dhsc-answers.bsky.social
A question on #BloodCancers #Diagnosis tabled by Ian Byrne on 21-10-2025 has been answered by Ashley Dalton. https://questions-statements.parliament.uk/written-questions/detail/2025-10-21/83963
October 29, 2025 at 8:20 PM
cancergrace.bsky.social
How do I treat Lower-Risk MDS?
Dr. @AshKishtagari

#BloodCancers #LowerRiskMDS
October 25, 2025 at 3:30 PM
pharmaphorum.bsky.social
One of the pioneers of in vivo #celltherapy, #UmojaBiopharma, has cleared another regulatory milestone after getting a #fasttrackdesignation from the FDA for its lead candidate for #bloodcancers, partnered with #AbbVie.
Umoja's in vivo cell therapy fast-tracked by FDA
A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.
buff.ly
October 1, 2025 at 1:30 PM
ihieurope.bsky.social
🩸 From mining #BigData to advancing #CarTCell therapies, our projects are working hard to improve the lives of people living with #BloodCancers like leukaemia
👉 Find out more at our online event on 1 October - sign up at europa.eu/!hdYgBh
#IHITransformingHealth #HorizonEU
Impact on Blood Cancer 01.10.2025 10:30 CET Online event Registration now open Meet the speakers Michael Hudecek, University Hospital Würzburg Jesús María Hernandez, University Hospital of Salamanca and ISBAL Sonja Steppan, Fresenius SE & Co, KGaA Lars Bullinger, Charité Universitätsmedizin Berlin Oussama Karroum, Innovative Health Initiative
September 16, 2025 at 9:35 AM
ndlrconference.bsky.social
We are excited to announce #NDLR2026 speaker, Assoc Prof @LevKats from @PeterMacCC. Lev's research includes #Epigenetic regulation, #Metabolism and #TargetedTherapies. His lab uses molecular and functional #Genomics to develop new treatment strategies for aggressive #BloodCancers
September 15, 2025 at 10:30 PM
ihieurope.bsky.social
🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering important results for patients
👩‍💻 Join us online on 1 October find out more!
👉 europa.eu/!hdYgBh
#IHITransformingHealth #CellTherapy
Impact on Blood Cancer Leveraging big data and CAR-T therapies to improve outcomes for patients 10:30-12:00 CET 01.10.2025
September 11, 2025 at 1:48 PM
newsen.bsky.social
Advancements in Blood Cancer Treatment by Florida Cancer Specialists at SOHO 2025#USA#Houston#FloridaCancerSpecialists#BloodCancers#SOHO2025
Advancements in Blood Cancer Treatment by Florida Cancer Specialists at SOHO 2025
Florida Cancer Specialists showcase groundbreaking research on blood cancer treatments at SOHO 2025, emphasizing real-world evidence and clinical advancements.
third-news.com
September 5, 2025 at 3:44 PM
ihieurope.bsky.social
🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering results.
👩‍💻 Join us online on 1 Oct 10:30–12:00 CET & find out more!
europa.eu/!hdYgBh
#BigDataInHealth #IHITransformingHealth
Impact on Blood Cancers
Leveraging big data and CAR-T therapies to improve outcomes for patients
www.ihi.europa.eu
September 5, 2025 at 8:56 AM
drmiguelperales.bsky.social
Great to see call to action by @nmdp-org.bsky.social at our local bus stop in NYC. Register to be a stem cell transplant donor and save a life! #bmtsm #bloodcancers
August 25, 2025 at 1:25 PM
capathfinders.bsky.social
📢Meet our Fellows

Simran Panda joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Anna Bigas at @carrerasijc.bsky.social.

👩‍🔬Learn about Simran carreraspathfinders.eu/doctoral-can...
and 🔬her project carreraspathfinders.eu/projects/dc10/

#MSCActions #bloodcancers #phd
July 28, 2025 at 12:42 PM
capathfinders.bsky.social
📢Meet our Fellows

Emilio Ruini joined #CarrerasPathfinders to pursue his PhD under the supervision of Dr @belverlab.bsky.social at @carrerasijc.bsky.social.

👨‍🔬Learn about Emilio carreraspathfinders.eu/doctoral-can...
and his project carreraspathfinders.eu/projects/dc9/

#MSCActions #bloodcancers
July 22, 2025 at 10:46 AM
maatpharma.bsky.social
📄 [Press release] – MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025.

👉 For more information, read the full press release: www.maatpharma.com/june-19-2025...

#BloodCancers #Cancer #aGvHD #Microbiome #MAA #EMA #Oncology #GeneralMeeting #Xervyteg #Business
June 19, 2025 at 5:15 PM
immunoeditor.bsky.social
New in #Science #Immunology: Researchers at Sun Yat-Sen University in Guangzhou report that #BloodCancers expressing PSGL-1 can prevent the #integrin signaling #macrophages need for #phagocytosis. Targeting PSGL-1 improved survival in mouse models of #leukemia, #lymphoma, & #MultipleMyeloma!
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance
PSGL-1 acts as a phagocytosis checkpoint to promote tumor immune escape through impeding LFA-1 activation in macrophages.
www.science.org
June 19, 2025 at 7:34 AM
capathfinders.bsky.social
📢Meet our Fellows

Isorchand Chongtham joined #CarrerasPathfinders to pursue his PhD supervised by Dr Sònia Guil
at @carrerasijc.bsky.social.

👨‍🔬Learn about Isorchand carreraspathfinders.eu/doctoral-can...
🔬about his project carreraspathfinders.eu/projects/dc7/

#MSCActions #bloodcancers
June 11, 2025 at 10:26 AM